Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Kidney, Autosomal Dominant | 4 | 2017 | 168 | 0.780 |
Why?
|
| Cilia | 4 | 2013 | 466 | 0.420 |
Why?
|
| Body Patterning | 1 | 2015 | 627 | 0.370 |
Why?
|
| Glomerulonephritis | 1 | 2008 | 370 | 0.280 |
Why?
|
| Paraproteinemias | 1 | 2008 | 246 | 0.270 |
Why?
|
| Lisinopril | 2 | 2014 | 55 | 0.250 |
Why?
|
| Polycystic Kidney Diseases | 3 | 2015 | 133 | 0.240 |
Why?
|
| Benzoates | 2 | 2014 | 216 | 0.220 |
Why?
|
| Aspartic Acid Proteases | 1 | 2022 | 9 | 0.210 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2022 | 23 | 0.210 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2023 | 131 | 0.200 |
Why?
|
| Carrier Proteins | 1 | 2015 | 5012 | 0.200 |
Why?
|
| Micropore Filters | 1 | 2020 | 23 | 0.190 |
Why?
|
| Multiple Myeloma | 3 | 2023 | 5147 | 0.180 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5833 | 0.180 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2020 | 163 | 0.180 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 260 | 0.170 |
Why?
|
| Benzimidazoles | 2 | 2014 | 848 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2014 | 1510 | 0.170 |
Why?
|
| TRPP Cation Channels | 2 | 2015 | 176 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 1330 | 0.130 |
Why?
|
| Retinitis Pigmentosa | 3 | 2013 | 387 | 0.130 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 1424 | 0.130 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2014 | 454 | 0.130 |
Why?
|
| Ciliary Motility Disorders | 2 | 2013 | 47 | 0.120 |
Why?
|
| Kidney Diseases, Cystic | 3 | 2013 | 185 | 0.120 |
Why?
|
| Drug Monitoring | 1 | 2020 | 961 | 0.120 |
Why?
|
| Ellis-Van Creveld Syndrome | 1 | 2013 | 7 | 0.120 |
Why?
|
| Medical History Taking | 1 | 2017 | 782 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2008 | 4220 | 0.110 |
Why?
|
| Encephalocele | 2 | 2013 | 138 | 0.110 |
Why?
|
| Heparin | 1 | 2020 | 1637 | 0.110 |
Why?
|
| Disease Progression | 5 | 2017 | 13237 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 2902 | 0.110 |
Why?
|
| Cerebellar Ataxia | 1 | 2013 | 139 | 0.110 |
Why?
|
| Zebrafish | 3 | 2013 | 2983 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2015 | 760 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2021 | 2933 | 0.100 |
Why?
|
| Mutation | 7 | 2023 | 29659 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2013 | 645 | 0.090 |
Why?
|
| Sequence Deletion | 2 | 2011 | 1526 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1941 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 4464 | 0.080 |
Why?
|
| Centrosome | 1 | 2009 | 198 | 0.080 |
Why?
|
| Critical Illness | 1 | 2020 | 2656 | 0.080 |
Why?
|
| Biological Transport | 1 | 2012 | 2117 | 0.070 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2008 | 249 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2015 | 5180 | 0.070 |
Why?
|
| Cochlea | 1 | 2013 | 830 | 0.070 |
Why?
|
| Zebrafish Proteins | 1 | 2013 | 1005 | 0.070 |
Why?
|
| Abnormalities, Multiple | 2 | 2013 | 1405 | 0.070 |
Why?
|
| Exons | 1 | 2011 | 2432 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 2039 | 0.060 |
Why?
|
| Proteins | 2 | 2011 | 6074 | 0.060 |
Why?
|
| Hypertension | 2 | 2014 | 8430 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2013 | 7861 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 2 | 2014 | 2546 | 0.060 |
Why?
|
| Complement Pathway, Alternative | 1 | 2023 | 126 | 0.050 |
Why?
|
| Phenotype | 4 | 2013 | 16300 | 0.050 |
Why?
|
| Retina | 1 | 2013 | 2633 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2015 | 23355 | 0.050 |
Why?
|
| Algorithms | 1 | 2021 | 13828 | 0.050 |
Why?
|
| Homeostasis | 1 | 2012 | 3346 | 0.050 |
Why?
|
| Rats | 2 | 2015 | 24259 | 0.050 |
Why?
|
| Cell Line | 1 | 2015 | 15982 | 0.050 |
Why?
|
| Factor Xa | 1 | 2020 | 162 | 0.040 |
Why?
|
| Humans | 20 | 2023 | 739219 | 0.040 |
Why?
|
| Kidney | 1 | 2014 | 7141 | 0.040 |
Why?
|
| Animals | 7 | 2021 | 168358 | 0.040 |
Why?
|
| Epidermolysis Bullosa, Junctional | 1 | 1997 | 12 | 0.040 |
Why?
|
| Equipment Failure Analysis | 1 | 2020 | 865 | 0.040 |
Why?
|
| Recurrence | 1 | 2008 | 8306 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 2014 | 2184 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5500 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1652 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 9812 | 0.030 |
Why?
|
| Prevalence | 1 | 2013 | 15152 | 0.030 |
Why?
|
| Male | 11 | 2021 | 348967 | 0.030 |
Why?
|
| Female | 12 | 2021 | 378808 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1997 | 657 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12134 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1998 | 436 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 80995 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1122 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2020 | 1453 | 0.030 |
Why?
|
| Survival Rate | 1 | 2008 | 12760 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 6478 | 0.030 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2013 | 25 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2021 | 2515 | 0.030 |
Why?
|
| Dyneins | 1 | 2013 | 123 | 0.030 |
Why?
|
| Ectodermal Dysplasia | 1 | 2013 | 102 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 38941 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 1998 | 903 | 0.030 |
Why?
|
| Point Mutation | 1 | 1997 | 1626 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2013 | 4138 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1997 | 1599 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 365 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 175 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2015 | 1470 | 0.020 |
Why?
|
| Cerebellar Diseases | 1 | 2013 | 226 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2014 | 11985 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2013 | 240 | 0.020 |
Why?
|
| Albuminuria | 1 | 2014 | 692 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 13815 | 0.020 |
Why?
|
| Middle Aged | 5 | 2021 | 212833 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 763 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2011 | 211 | 0.020 |
Why?
|
| Aldosterone | 1 | 2014 | 870 | 0.020 |
Why?
|
| Organ Size | 1 | 2014 | 2248 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 1883 | 0.020 |
Why?
|
| Craniosynostoses | 1 | 2013 | 398 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 18124 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3505 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 62691 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1998 | 1177 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2014 | 8553 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3433 | 0.020 |
Why?
|
| Neural Tube | 1 | 2008 | 46 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3672 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6294 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10939 | 0.020 |
Why?
|
| Pedigree | 2 | 2011 | 4641 | 0.020 |
Why?
|
| Microinjections | 1 | 2008 | 326 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 2257 | 0.020 |
Why?
|
| Alleles | 2 | 2013 | 6939 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 940 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2008 | 432 | 0.020 |
Why?
|
| Cerebellum | 1 | 2013 | 1513 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 2100 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 1893 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2020 | 4582 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 1369 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 1988 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2008 | 954 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4174 | 0.010 |
Why?
|
| Adult | 4 | 2014 | 213375 | 0.010 |
Why?
|
| Fetus | 1 | 2011 | 1877 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 162667 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2013 | 2574 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2552 | 0.010 |
Why?
|
| Proteomics | 1 | 2015 | 3584 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 3849 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 2216 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2008 | 76632 | 0.010 |
Why?
|
| Base Sequence | 1 | 2011 | 12807 | 0.010 |
Why?
|
| Genomics | 1 | 2015 | 5655 | 0.010 |
Why?
|
| Young Adult | 2 | 2014 | 56252 | 0.010 |
Why?
|
| Adolescent | 2 | 2014 | 85409 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 9381 | 0.010 |
Why?
|
| Child | 1 | 2023 | 77029 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18002 | 0.010 |
Why?
|
| Homozygote | 1 | 1997 | 1788 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 15500 | 0.010 |
Why?
|
| Haplotypes | 1 | 1997 | 2783 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1997 | 1811 | 0.010 |
Why?
|
| Heterozygote | 1 | 1997 | 2796 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 4744 | 0.010 |
Why?
|
| Genotype | 1 | 1998 | 12950 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1997 | 25470 | 0.000 |
Why?
|
| Pregnancy | 1 | 1998 | 29003 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1998 | 40801 | 0.000 |
Why?
|
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_